1. Home
  2. MXF vs ORGO Comparison

MXF vs ORGO Comparison

Compare MXF & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Fund Inc. (The)

MXF

Mexico Fund Inc. (The)

HOLD

Current Price

$22.00

Market Cap

311.9M

Sector

Finance

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.49

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXF
ORGO
Founded
N/A
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.9M
348.6M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
MXF
ORGO
Price
$22.00
$2.49
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
53.0K
1.1M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
N/A
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.04
52 Week Low
$16.43
$2.04
52 Week High
$23.00
$7.08

Technical Indicators

Market Signals
Indicator
MXF
ORGO
Relative Strength Index (RSI) 51.74 48.76
Support Level $20.96 $2.26
Resistance Level $22.34 $2.67
Average True Range (ATR) 0.42 0.15
MACD 0.00 -0.02
Stochastic Oscillator 59.25 52.85

Price Performance

Historical Comparison
MXF
ORGO

About MXF Mexico Fund Inc. (The)

Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: